Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ecotone is an AI-first biotechnology company focused on developing foundational models for biology to accelerate the discovery of novel therapeutics. By leveraging generative AI and large-scale biological datasets, the company aims to decode complex biological systems and design high-precision medicines. Their platform is designed to identify novel targets and optimize molecular candidates across a variety of therapeutic modalities, including proteins and small molecules. Ecotone integrates advanced machine learning with experimental biology to streamline the drug development process from initial discovery to clinical entry. The company's mission is to build the computational foundation for the next generation of medicine, reducing the time and cost of traditional R&D. Headquartered in San Francisco, Ecotone is led by experts in both deep learning and molecular biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecotone AI.